As menopausal status is one of the risk factors for developing ovarian cancer, we then compared the positivity of ER or PR in patients with epithelial ovarian cancer before menopause or after menopause according to the cancer type (Table 3). This evidence concerns the gene PGR and ovarian carcinoma.